TXG Stock Analysis: Buy, Sell, or Hold?
TXG - 10x Genomics, Inc. Class A Common Stock
$47.27
-2.16 (-4.37%)
▼
5d:
+2.16%
30d:
+21.05%
90d:
+114.38%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
3d
Get Alerted When TXG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: TXG shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: TXG shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.24
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.50
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TXG is currently trading at $47.27, which is considered extended relative to its 30-day fair value range of $37.04 to $46.82. From a valuation perspective, the stock is trading at a premium (Forward PE: 228.7) compared to its historical average (145.8). At these levels, the market is pricing in 16.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TXG is in a strong uptrend. Immediate support is located at $41.93, while resistance sits at $50.34. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $41.54. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TXG is in a strong uptrend. Immediate support is located at $41.93, while resistance sits at $50.34. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $41.54. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$37.04 -
$46.82
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
35.7%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.4%)
- BEARISH: Trading 12.1% above Wall St target ($41.54)
- NEUTRAL: Trading at premium valuation - market expects 16.2% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$37.04 -
$46.82
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$41.93
Resistance Level
$50.34
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
228.69
Wall Street Target
$41.54
(-12.1%)
Revenue Growth (YoY)
-2.6%
Profit Margin
-3.5%
Valuation Premium vs History
+16.2% premium
PE vs Historical
228.7 vs 145.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+16.2%
(market-implied from PE analysis)
1-Year Target
$54.93
(+16%)
2-Year Target
$63.83
(+35%)
3-Year Target
$74.17
(+57%)
3-Yr Target (if PE normalizes)
(PE: 229→146)
PE COMPRESSION
$47.28
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: August 02, 2026 1:11 PM ET
Data refreshes hourly during market hours. Next update: 2:11 PM
Data refreshes hourly during market hours. Next update: 2:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TXG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Serge Saxonov
SELL
5000 shares
2026-04-14
Serge Saxonov
SELL
5000 shares
2026-03-24
Serge Saxonov
SELL
10000 shares
2026-03-23
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 59 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 53 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 49 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 50 HOLD |
